-
公开(公告)号:US20250051778A1
公开(公告)日:2025-02-13
申请号:US17605998
申请日:2020-04-24
Applicant: WAVE LIFE SCIENCES LTD.
Inventor: Michael John Byrne , Vinod Vathipadiekal , Naoki Iwamoto , Chandra Vargeese , Lankai Guo
IPC: C12N15/113
Abstract: Among other things, the present disclosure provides USH2A oligonucleotides, and compositions and methods of use thereof, for preventing and/or treating various conditions, disorders or diseases. In some embodiments, provided USH2A oligonucleotides comprise nucleobase modifications, sugar modifications, internucleotidic linkage modifications and/or patterns thereof, and have improved properties, activities and/or selectivities. In some embodiments, the present disclosure provides USH2A oligonucleotides, compositions and methods for preventing and/or treating USH2A-related conditions, disorders or diseases, such as Usher Syndrome (e.g., Usher Syndrome Type 2A), atypical Usher syndrome, or nonsyndromic retinitis pigmentosa.
-
公开(公告)号:US20230145795A1
公开(公告)日:2023-05-11
申请号:US17605997
申请日:2020-04-24
Applicant: WAVE LIFE SCIENCES LTD.
Inventor: Michael John Byrne , Vinod Vathipadiekal , Naoki Iwamoto , Chandra Vargeese , Lankai Guo , Andrew Guzior Hoss
IPC: C12N15/113 , A61P27/00
CPC classification number: C12N15/1138 , A61P27/00 , C12N2310/315 , C12N2310/351
Abstract: Among other things, the present disclosure provides RHO oligonucleotides, compositions, and methods. In some embodiments, provided oligonucleotides comprise nucleobase modifications, sugar modifications, internucleotidic linkage modifications and/or patterns thereof, and have improved properties, activities and/or selectivities. In some embodiments, the present disclosure provides RHO oligonucleotides, compositions and methods for preventing and/or treating RHO-related conditions, disorders or diseases, such as retinopathy (e.g, retinal degeneration, retinal degenerative disease, retinal degenerative disorder, inherited retinal degenerative disorder, retinitis pigmentosa, autosomal dominant retinitis pigmentosa, etc.).
-